The global Anti-Inflammatory Analgesic and Antipyretic Drugs Market growth is projected to reach US$ 2787 million in 2025 to US$ 3095 million in 2031; it is expected to grow at a CAGR of 1.8% from 2025 to 2031.

Global Anti-Inflammatory Analgesic and Antipyretic Drugs Market Growth And Outlook 2025-31

The global Anti-Inflammatory Analgesic and Antipyretic Drugs market size is predicted to grow from US$ 2787 million in 2025 to US$ 3095 million in 2031; it is expected to grow at a CAGR of 1.8% from 2025 to 2031. Anti-Inflammatory Analgesic and Antipyretic Drug can make the body temperature of a febrile patient return to normal, but have no effect on normal body temperature. These drugs also have moderate analgesic effects, but not as strong as morphine and its synthetic substitutes. Commonly used antipyretic and analgesic drugs can be divided into salicylic acid, aniline and pyrazolone according to their chemical structure. Among them, except aniline drugs have anti-rheumatic effect, but also can treat rheumatism and rheumatoid arthritis. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs. Infinity Market Research newest research report, the ?Anti-Inflammatory Analgesic and Antipyretic Drugs Industry Forecast? looks at past sales and reviews total world Anti-Inflammatory Analgesic and Antipyretic Drugs sales in 2024, providing a comprehensive analysis by region and market sector of projected Anti-Inflammatory Analgesic and Antipyretic Drugs sales for 2025 through 2031. With Anti-Inflammatory Analgesic and Antipyretic Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Anti-Inflammatory Analgesic and Antipyretic Drugs industry. This Insight Report provides a comprehensive analysis of the global Anti-Inflammatory Analgesic and Antipyretic Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Anti-Inflammatory Analgesic and Antipyretic Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Anti-Inflammatory Analgesic and Antipyretic Drugs market. This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Anti-Inflammatory Analgesic and Antipyretic Drugs and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Anti-Inflammatory Analgesic and Antipyretic Drugs. This report presents a comprehensive overview, market shares, and growth opportunities of Anti-Inflammatory Analgesic and Antipyretic Drugs market by product type, application, key manufacturers and key regions and countries. Segmentation by Type: &nbsp;&nbsp;&nbsp; Paracetamol &nbsp;&nbsp;&nbsp; Aspirin &nbsp;&nbsp;&nbsp; Ibuprofen &nbsp;&nbsp;&nbsp; Naproxen &nbsp;&nbsp;&nbsp; Diclofenac &nbsp;&nbsp;&nbsp; Oxaprozin &nbsp;&nbsp;&nbsp; Dexibuprofen &nbsp;&nbsp;&nbsp; Others Segmentation by Application: &nbsp;&nbsp;&nbsp; Adults &nbsp;&nbsp;&nbsp; Children This report also splits the market by region: &nbsp;&nbsp;&nbsp; Americas &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; United States &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Canada &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Mexico &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Brazil &nbsp;&nbsp;&nbsp; APAC &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; China &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Japan &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Korea &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Southeast Asia &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; India &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Australia &nbsp;&nbsp;&nbsp; Europe &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Germany &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; France &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; UK &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Italy &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Russia &nbsp;&nbsp;&nbsp; Middle East & Africa &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Egypt &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; South Africa &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Israel &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Turkey &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; GCC Countries The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the companys coverage, product portfolio, its market penetration. &nbsp;&nbsp;&nbsp; Mallinckrodt Pharmaceuticals &nbsp;&nbsp;&nbsp; IOL &nbsp;&nbsp;&nbsp; Anqiu Luan Pharmaceutical &nbsp;&nbsp;&nbsp; Novacyl &nbsp;&nbsp;&nbsp; BASF &nbsp;&nbsp;&nbsp; Anhui BBCA Pharmaceuticals &nbsp;&nbsp;&nbsp; Hubei Biocause &nbsp;&nbsp;&nbsp; Xinhua Pharm &nbsp;&nbsp;&nbsp; Granules India Limited &nbsp;&nbsp;&nbsp; Huagang Pharm &nbsp;&nbsp;&nbsp; Hebei Jiheng Pharmaceutical &nbsp;&nbsp;&nbsp; Zhejiang Kangle Pharmaceutical &nbsp;&nbsp;&nbsp; Hebei Jingye Medical Technology &nbsp;&nbsp;&nbsp; MSPF &nbsp;&nbsp;&nbsp; Luan Pharmaceutical &nbsp;&nbsp;&nbsp; Mallinckrodt &nbsp;&nbsp;&nbsp; Farmson &nbsp;&nbsp;&nbsp; Anhui Fubore &nbsp;&nbsp;&nbsp; SKPL &nbsp;&nbsp;&nbsp; Atabay &nbsp;&nbsp;&nbsp; Huzhou Konch Pharmaceutical &nbsp;&nbsp;&nbsp; Anhui Topsun &nbsp;&nbsp;&nbsp; SOLARA &nbsp;&nbsp;&nbsp; SI Group Key Questions Addressed in this Report What is the 10-year outlook for the global Anti-Inflammatory Analgesic and Antipyretic Drugs market? What factors are driving Anti-Inflammatory Analgesic and Antipyretic Drugs market growth, globally and by region? Which technologies are poised for the fastest growth by market and region? How do Anti-Inflammatory Analgesic and Antipyretic Drugs market opportunities vary by end market size? How does Anti-Inflammatory Analgesic and Antipyretic Drugs break out by Type, by Application?

Report	Global Anti-Inflammatory Analgesic and Antipyretic Drugs Market Growth 2025-2031
Selected License	Multi ID: LPI9832

Buyer Information

Order Summary